Results from several large clinical trials on cancers of the colon, rectum, and anus have failed to fulfill hopes for better treatments. Findings presented at the 45th Annual Meeting of the American Society of Clinical Oncology (ASCO), held May 29 through June 2 in Orlando, indicate that in most cases, the current standards of care should remain the treatments of choice. However, one potentially practice-changing trial suggested that many patients with advanced colorectal cancer can forgo standard surgery and receive chemotherapy as first-line care.
Register and get free email Table of Contents alerts, saved searches, PowerPoint downloads, CME quizzes, and more
Subscribe for full-text access to content from 1998 forward and a host of useful features
Activate your current subscription (AMA members and current subscribers)
Purchase Online Access to this article for 24 hours
Graphic Jump Location
Chemotherapy should replace surgery as initial treatment for many patients with certain types of colorectal cancer, according to clinical trials.
Some tools below are only available to our subscribers or users with an online account.
Download citation file:
Web of Science® Times Cited: 2
Customize your page view by dragging & repositioning the boxes below.
More Listings atJAMACareerCenter.com >
and access these and other features:
Enter your username and email address. We'll send you a link to reset your password.
Enter your username and email address. We'll send instructions on how to reset your password to the email address we have on record.
Athens and Shibboleth are access management services that provide single sign-on to protected resources. They replace the multiple user names and passwords necessary to access subscription-based content with a single user name and password that can be entered once per session. It operates independently of a user's location or IP address. If your institution uses Athens or Shibboleth authentication, please contact your site administrator to receive your user name and password.